What was the consensus EPS estimate for Q2 2025 and how does the reported adjusted EPS of $0.30 compare?
Answer
The news release you provided does not include the consensus (analyst) earnings‑per‑share (EPS) estimate for AMN Healthcare’s second‑quarter 2025 results.
Because the consensus EPS figure isn’t supplied in the information you gave, we can’t directly compare it to the company‑reported adjusted EPS of $0.30 per share.
What this means for you
Item | Value (from the press release) |
---|---|
Reported adjusted EPS (Q2 2025) | $0.30 per share |
Consensus EPS estimate (Q2 2025) | Not disclosed in the provided excerpt |
How to interpret the comparison (once the consensus estimate is known)
If the consensus estimate were **higher than $0.30 (e.g., $0.35 or $0.40), the company’s adjusted EPS would be **below analyst expectations, suggesting a potential disappointment to investors and a likelihood that the stock price could face downward pressure, all else equal.
If the consensus estimate were **lower than $0.30 (e.g., $0.25 or $0.20), the company’s adjusted EPS would be **above expectations, which generally would be viewed positively by the market, potentially supporting a price uptick.
If the consensus estimate were **about the same as $0.30 (within a few cents), the result would be considered in‑line with expectations, and the market reaction would likely hinge on other factors (revenue growth, cash flow, guidance, etc.) rather than the EPS number alone.
What you can do next
Locate the consensus estimate – This is typically available from:
- Financial data platforms (Bloomberg, Refinitiv, FactSet, Zacks, Yahoo! Finance, etc.).
- Brokerage research notes that published the consensus prior to the earnings release.
- Earnings preview articles (often posted a few days before the earnings date) that summarize analyst expectations.
Compare the numbers – Once you have the consensus EPS figure:
- Subtract it from the reported adjusted EPS ($0.30) to compute the absolute and percentage deviation.
- Consider the broader context (revenue beat, profit margins, guidance) to assess whether the EPS difference is likely to be a significant market driver.
Summary: The provided news excerpt does not specify a consensus EPS estimate for Q2 2025, so we cannot directly compare it to the reported adjusted EPS of $0.30 per share. You’ll need to retrieve the consensus estimate from the sources listed above to make a full comparison.